This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cancer Research UK. Brain cancer (C71): 2010-2011. One-, five- and ten-year net survival (%), adults aged 15-99, England & Wales. [cited 2017 Avg 15]. Available at: http://info.cancerresearchuk.org/cancerstats/faqs/#How.Cancer Research UK. Brain cancer (C71)2010-2011One-, five- and ten-year net survival (%), adults aged 15-99, England & Wales[cited 2017 Avg 15]. Available athttp://info.cancerresearchuk.org/cancerstats/faqs/#HowSearch in Google Scholar
Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Geraci M, et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003. Eur J Cancer 2010; 46: 1607-16. 10.1016/j.ejca.2010.02.007AroraRSAlstonRDEdenTOEstlinEJMoranAGeraciMAre reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003Eur J Cancer20104616071610.1016/j.ejca.2010.02.00720194015Open DOISearch in Google Scholar
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 2012; 14(Suppl 5): v1–49. 10.1093/neuonc/nos218DolecekTAProppJMStroupNEKruchkoC.CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009Neuro Oncol2012145v14910.1093/neuonc/nos218348024023095881Open DOISearch in Google Scholar
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, et al. CBTRUS statistical report: primary brain and central nervous aystem tumors diagnosed in the United States in 2008-2012. Neuro Oncol 2015; 17(Suppl 4): iv1-62. 10.1093/neuonc/nov189OstromQTGittlemanHFulopJLiuMBlandaRKromerCWolinskyYCBTRUS statistical report: primary brain and central nervous aystem tumors diagnosed in the United States in 2008-2012Neuro Oncol2015174iv16210.1093/neuonc/nov189462324026511214Open DOISearch in Google Scholar
Cancer incidence in Slovenia1997-2006. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2000-2009.Cancer incidence in Slovenia1997-2006LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia20002009Search in Google Scholar
Cancer in Slovenia 2007-11. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2010-2014.Cancer in Slovenia 2007-11LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia20102014Search in Google Scholar
Smrdel U, Kovac V, Popovic M, Zwitter M. Glioblastoma patients in Slovenia from 1997 to 2008. Radiol Oncol 2014; 48: 72-9. 10.2478/raon-2014-0002SmrdelUKovacVPopovicMZwitterM.Mlioblastoma patients in Slovenia from 1997 to 2008Radiol Oncol20144872910.2478/raon-2014-0002390885124587783Open DOISearch in Google Scholar
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre P-L, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 6892-9. 10.1158/0008-5472.CAN-04-1337OhgakiHDessenPJourdeBHorstmannSNishikawaTDi PatreP-LGenetic pathways to glioblastoma: a population-based studyCancer Res2004646892910.1158/0008-5472.CAN-04-133715466178Open DOISearch in Google Scholar
Steinfeld AD, Donahue B, Walker I. Delay in the diagnosis of glioblastoma multiforme: is age a factor? Cancer Invest 1996; 14: 317-9.SteinfeldADDonahueBWalkerI.Ielay in the diagnosis of glioblastoma multiforme: is age a factor?Cancer Invest199614317910.3109/073579096090121578689425Search in Google Scholar
Crespo I, Vital AL, Gonzalez-Tablas M, Patino M del C, Otero A, Lopes MC, et al. Molecular and genomic alterations in glioblastoma multiforme. Am J Pathol 2015; 185: 1820-33. 10.1016/j.ajpath.2015.02.023CrespoIVitalALGonzalez-TablasMPatinoMdelCOteroALopesMCMolecular and genomic alterations in glioblastoma multiformeAm J Pathol201518518203310.1016/j.ajpath.2015.02.02325976245Open DOISearch in Google Scholar
De Groot JF, Aldape KD CH. High-grade astrocytomas. In: Schiff D, On B, editors. Principles of neuro-oncology. New York: McGraw Hill; 2005. p. 259-88.De GrootJFAldapeKD CH.High-grade astrocytomasSchiffDOnBPrinciples of neuro-oncologyNew YorkMcGraw Hill200525988Search in Google Scholar
Biau J, Dalloz P, Durando X, Hager MO, Ouédraogo ZG, Khalil T, et al. [Elderly patients with glioblastoma: state of the art].[French]. Bull Cancer2015; 102: 277-86. 10.1016/j.bulcan.2015.02.002BiauJDallozPDurandoXHagerMOOuédraogoZGKhalilT[Elderly patients with glioblastoma: state of the art].[French]Bull Cancer20151022778610.1016/j.bulcan.2015.02.00225732048Open DOISearch in Google Scholar
Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ, et al. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 2011; 81: 623-30. 10.1016/j.ijrobp.2010.06.012LiJWangMWonMShawEGCoughlinCCurranWJValidation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaInt J Radiat Oncol Biol Phys2011816233010.1016/j.ijrobp.2010.06.012378321120888136Open DOISearch in Google Scholar
Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST, et al. Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 2012; 118: 5595-600. 10.1002/cncr.27570ScottJGBauchetLFraumTJNayakLCooperARChaoSTRecursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderCancer2012118559560010.1002/cncr.27570340265222517216Open DOISearch in Google Scholar
Arvold ND, Reardon DA. Treatment options and outcomes for glioblastoma in the elderly patient. Clin Interv Aging 2014; 9: 357-67. 10.2147/CIA.S44259ArvoldNDReardonDA.DAreatment options and outcomes for glioblastoma in the elderly patientClin Interv Aging201493576710.2147/CIA.S44259393710324591820Open DOISearch in Google Scholar
Lönn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen HC, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004; 108: 450-5. 10.1002/ijc.11578LönnSKlaeboeLHallPMathiesenTAuvinenAChristensenHCIncidence trends of adult primary intracerebral tumors in four Nordic countriesInt J Cancer2004108450510.1002/ijc.1157814648713Open DOISearch in Google Scholar
Statistical Office, Republic of Slovenia. Births and deaths. [Internet]. [cited 2017 Nov 19]. Available at: http://www.stat.si/StatWeb/Field/Index/17/95Statistical Office, Republic of Slovenia. Births and deaths[Internet]. [cited 2017 Nov 19]. Available athttp://www.stat.si/StatWeb/Field/Index/17/95Search in Google Scholar
OECDiLibrary. Health at a glance 2017. [Internet]. OECD Publishing; 2017 [cited 2017 Nov 19]. Available at: http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-enOECDiLibraryHealth at a glance 2017[Internet]. OECD Publishing2017[cited 2017 Nov 19]. Available athttp://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-enSearch in Google Scholar
Fiorentino A, De Bonis P, Chiesa S, Balducci M, Fusco V. Elderly patients with glioblastoma: the treatment challenge. Expert Rev Neurother 2013; 13: 1099-105. 10.1586/14737175.2013.840419FiorentinoADe BonisPChiesaSBalducciMFuscoV.Vlderly patients with glioblastoma: the treatment challengeExpert Rev Neurother201313109910510.1586/14737175.2013.84041924117272Open DOISearch in Google Scholar
Reardon D, Arvold N. Treatment options and outcomes for glioblastoma in the elderly patient. Clin Interv Aging 2014; 9: 357-67. 10.2147/CIA.S44259ReardonDArvoldN.Nreatment options and outcomes for glioblastoma in the elderly patientClin Interv Aging201493576710.2147/CIA.S44259Open DOISearch in Google Scholar
Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabro M, et al. Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. Neurosurg Rev 2014; 3: 415-23. 10.1007/s10143-014-0528-8ZouaouiSDarlixAFabbro-PerayPMathieu-DaudéHRigauVFabroMOncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in FranceNeurosurg Rev201434152310.1007/s10143-014-0528-824526367Open DOISearch in Google Scholar
Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. N Eng J Med 2007; 356: 1527-35. 10.1056/NEJMoa065901Keime-GuibertFChinotOTaillandierLCartalat-CarelSFrenayMKantorGRadiotherapy for glioblastoma in the elderlyN Eng J Med200735615273510.1056/NEJMoa06590117429084Open DOISearch in Google Scholar
Smrdel U, Popovic M, Zwitter M, Bostjancic E, Zupan A, Kovac V, et al. Longterm survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor. Radiol Oncol 2016; 50: 394-401. 10.1515/raon-2015-0041SmrdelUPopovicMZwitterMBostjancicEZupanAKovacVLongterm survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factorRadiol Oncol20165039440110.1515/raon-2015-0041512057227904447Open DOISearch in Google Scholar
